4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-009554
Options or other derivatives
- Director acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lucera Erick Director | 2023-04-03 | Grant or award · Employee Stock Option (right to buy) | +25,000 | 25,000 | D | ||
Loading xslF345X04/rdgdoc.xml…